COMBINED USE OF A SULFATED GLYCOSAMINOGLYCAN AND A HYALURONIDASE FOR IMPROVING THE BIOAVAILABILITY OF FACTOR VIII
- Application ID: EP12772969
- Status: █ PATENT GRANTED
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). CSL Behring GmbH is specialized in A61. CSL Behring GmbH is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.